ProCE Banner Activity

Overview of Frontline Treatment of PTCL: A Clinician’s Guide and Resource

PDF
Review expert recommendations for management of newly diagnosed PTCL with this downloadable PDF resource guide.

Released: July 23, 2019

Expiration: July 21, 2020

No longer available for credit.

Share

Faculty

Helen Hancock

Helen Hancock, NP

Clinical Trials Nurse Practitioner
T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
New York, New York

Steven M. Horwitz

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Seagen

Faculty Disclosure

Primary Author

Helen Hancock, NP

Clinical Trials Nurse Practitioner
T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
New York, New York

Helen Hancock, NP, has no relevant financial relationships to disclose.

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Steven M. Horwitz, MD, has disclosed that he has received funds for research support from ADC Therapeutics, Aileron, Celgene, Forty Seven, Infinity/Verastem, Kyowa-Hakko-Kirin, Millennium/Takeda, Seattle Genetics, and Trillium and consulting fees from ADC Therapeutics, Affimed, Aileron, Angimmune, BeiGene, Corvus, Forty Seven, Infinity/Verastem, Innate Pharma, Kura, Kyowa-Hakko-Kirin, Merck, Millennium/Takeda, miRagen, Mundipharma, Portola, Seattle Genetics, and Syros.